arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Social Sciences · Education

Group-Based Optimization\nof Potent and Cell-Active\nInhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase:\nStructure–Activity Relationships Leading to the Chemical Probe\n(2<i>S</i>,4<i>R</i>)‑1-((<i>S</i>)‑2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy‑<i>N</i>‑(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide\n(VH298)

Pedro Soares (393566), Morgan S. Gadd (149371), Julianty Frost (4441813), Carles Galdeano (1305135), Lucy Ellis (3223065), Ola Epemolu (3012306), Sonia Rocha (231588), Kevin D. Read (165019), Alessio Ciulli (762789)

· Figshare

See on the map

Abstract

The\nvon Hippel–Lindau tumor suppressor protein is the substrate\nbinding subunit of the VHL E3 ubiquitin ligase, which targets hydroxylated\nα subunit of hypoxia inducible factors (HIFs) for ubiquitination\nand subsequent proteasomal degradation. VHL is a potential target\nfor treating anemia and ischemic diseases, motivating the development\nof inhibitors of the VHL:HIF-α protein–protein interaction.\nAdditionally, bifunctional proteolysis targeting chimeras (PROTACs)\ncontaining a VHL ligand can hijack the E3 ligase activity to induce\ndegradation of target proteins. We report the structure-guided design\nand group-based optimization of a series of VHL inhibitors with low\nnanomolar potencies and improved cellular permeability. Structure–activity\nrelationships led to the discovery of potent inhibitors <b>10</b> and chemical probe VH298, with dissociation constants <100 nM,\nwhich induced marked HIF-1α intracellular stabilization. Our\nstudy provides new chemical tools to probe the VHL-HIF pathways and\nnew VHL ligands for next-generation PROTACs.

More like this